In recent years, Gamma delta (γδ) T cells have become a potential avenue for adoptive immunotherapy. To date, a number of clinical trials have used γδ T cells for cancer treatment. And this type of cell has special characteristics: MHC-unrestricted cytotoxicity, secrete inflammatory cytokines, ability to distinguish transformed cells from normal cells, as well as promote the formation of antigen-specific CD81 and CD41 T cell response. Due to the important function of γδ T cell in several diseases, it is necessary to develop suitable clinical assays for γδ T cell activity and cytotoxicity.
Creative Biolabs is a leader in the research of γδ T cells and cancer immunotherapy, we provide comprehensive γδ T cells cytotoxicity test services, including LDH cytotoxicity test, flow cytometry-based cytotoxicity test, chromium-51 release assay, impedance-based label-free real-time cytotoxicity assay…
Learn more: t cell killing
